Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-05-22

FDA Approved: RIFAMPIN — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved an Original Application for rifampin from Mylan Institutional LLC, enabling a generic rifampin product. This action approves the generic formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFAMPIN (RIFAMPIN)

Snippet

ORIG AP for RIFAMPIN (RIFAMPIN)